enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Better Business Bureau (BBB) complaints and accreditation ...

   www.aol.com/lifestyle/better-business-bureau-bbb...

   With a legacy of more than 100 years, the Better Business Bureau (BBB) is the go-to watchdog for evaluating businesses and charities. The nonprofit organization maintains a massive database of ...

3. Selective serotonin reuptake inhibitor - Wikipedia

   en.wikipedia.org/wiki/Selective_serotonin...

   In 2018, a systematic review and network meta-analysis comparing the efficacy and acceptability of 21 antidepressant drugs showed escitalopram to be one of the most effective. They showed that "In terms of efficacy, all antidepressants were more effective than placebo, with odds ratios (ORs) ranging between 2.13 (95% credible interval [CrI] 1. ...

4. Vilazodone - Wikipedia

   en.wikipedia.org/wiki/Vilazodone

   [15] A 2019 review stated that "present studies do not suggest the superiority of vilazodone compared with other antidepressants." [16] Development of vilazodone for generalized anxiety disorder has been stopped as of 2017. [17] While there is tentative evidence of a small benefit in generalized anxiety disorder, there is a high rate of side ...

5. Meprobamate - Wikipedia

   en.wikipedia.org/wiki/Meprobamate

   Meprobamate—marketed as Miltown by Wallace Laboratories and Equanil by Wyeth, among others—is a carbamate derivative used as an anxiolytic drug. It was the best-selling minor tranquilizer for a time, but has largely been replaced by the benzodiazepines due to their wider therapeutic index (lower risk of toxicity at therapeutically prescribed doses) and lower incidence of serious side effects.

6. A 'yoga pill' to end anxiety? Neuroscientists discover a ...

   www.aol.com/news/yoga-pill-end-anxiety...

   A new study from the Salk Institute for Biological Studies has identified a brain circuit that slows the breath to calm the mind.

7. Escitalopram - Wikipedia

   en.wikipedia.org/wiki/Escitalopram

   A 2013 review [38] discusses several reasons to be optimistic about the safety of escitalopram. It references a crossover study in which 113 subjects were each given four different treatments in randomized order: placebo, 10 mg/day escitalopram, 30 mg/day escitalopram, or 400 mg/day moxifloxacin (a positive control known to cause QTc prolongation).